Medical Journal today has published in its print edition (I could not find the link in your digital edition) two columns on-TKM PLK-1, a drug that based on the technique of RNA interference, is directed by invitro studies against the protein kinase Polo-like-1 (Plk1), preventing cell division and facilitating apoptosis.
I refer here to this technique because it was the same who, while claiming the opposite effect, I had the chance to meet six years ago in the laboratory of Dr. Bähr at the University of Göttingen, where he investigated with models retinal ganglion cells apoptosis process and how to get his arrest in order to shed light on diseases in which programmed cell death appeared to be critical, as was the case with the cells of the substantia nigra in Parkinson disease.
0 comments:
Post a Comment